Micron delivered a blowout fiscal Q3, reporting $41.46B revenue (+350% YoY, +74% sequential) and EPS of $25.11 (about $5 above analysts’ expectations). For the current quarter it guided $50B revenue and $31 EPS (+21% and +23% sequential), while adding strategic customer agreements with 5-year terms into 2030 that generated $22B in deposits and imply ~$100B cumulative revenue potential. Despite the stock’s surge to an ~$1.3T market cap and ~11x forward earnings, analyst activity turned largely upgrade-driven, though investors are still weighing how pricing/capacity normalization could affect forward growth.
Micron is transitioning from a spot-pricing story to a contracted-capacity story, which matters because it lowers earnings beta and can justify a structurally higher multiple if management can keep returns on incremental wafer starts above cost of capital. The second-order winner is the memory supply chain: equipment vendors and specialty materials gain a multi-year capex runway if these agreements really backstop expansion, while the first-order loser set is anyone depending on cheap memory to preserve margin — especially AI server OEMs and lower-end consumer hardware. NVDA is less threatened on demand than on bill-of-materials pressure; the more vulnerable names are those with weaker pricing power that cannot fully pass through higher DRAM/HBM costs.
The key risk is that the market may be extrapolating a near-term shortage into a 6-18 month structural regime before we have proof that end-demand can absorb the new capacity. In the next 1-3 months, the stock will trade on whether management raises capex again without signaling margin normalization, and whether competitors increase supply faster than expected; that would be the first falsifier. Over 6-18 months, the real test is whether AI infrastructure spend remains strong enough to prevent a memory downcycle once the current contract window starts rolling forward.
Contrarian view: the rally may not be over if investors are still valuing Micron like a cyclical semi instead of a quasi-contracted infrastructure supplier. But for new money, the risk/reward is less attractive after the rerate; the cleaner setup is to buy weakness, not strength, unless we get evidence that the backlog converts into durable free cash flow rather than just deferred revenue visibility. If DRAM spot prices weaken or hyperscaler capex pauses, the multiple can compress quickly even with solid reported earnings.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Overall Sentiment
strongly positive
Sentiment Score
0.75
Ticker Sentiment